Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes.
Jonker JT, Wang Y, de Haan W, Diamant M, Rijzewijk LJ, van der Meer RW, Lamb HJ, Tamsma JT, de Roos A, Romijn JA, Rensen PC, Smit JW. Jonker JT, et al. Among authors: rijzewijk lj. Diabetes Care. 2010 Jul;33(7):1625-8. doi: 10.2337/dc09-1935. Epub 2010 Feb 11. Diabetes Care. 2010. PMID: 20150294 Free PMC article. Clinical Trial.
Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
van Lierop AH, Hamdy NA, van der Meer RW, Jonker JT, Lamb HJ, Rijzewijk LJ, Diamant M, Romijn JA, Smit JW, Papapoulos SE. van Lierop AH, et al. Among authors: rijzewijk lj. Eur J Endocrinol. 2012 Apr;166(4):711-6. doi: 10.1530/EJE-11-1061. Epub 2012 Jan 20. Eur J Endocrinol. 2012. PMID: 22267280 Clinical Trial.
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.
van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M. van der Meer RW, et al. Among authors: rijzewijk lj. Circulation. 2009 Apr 21;119(15):2069-77. doi: 10.1161/CIRCULATIONAHA.108.803916. Epub 2009 Apr 6. Circulation. 2009. PMID: 19349323 Free article. Clinical Trial.
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, Bax JJ, de Roos A, Heine RJ, Twisk JW, Windhorst AD, Lammertsma AA, Smit JW, Diamant M, Lamb HJ. Rijzewijk LJ, et al. J Am Coll Cardiol. 2010 Jul 13;56(3):225-33. doi: 10.1016/j.jacc.2010.02.049. J Am Coll Cardiol. 2010. PMID: 20620743 Free article.
Right ventricular involvement in diabetic cardiomyopathy.
Widya RL, van der Meer RW, Smit JW, Rijzewijk LJ, Diamant M, Bax JJ, de Roos A, Lamb HJ. Widya RL, et al. Among authors: rijzewijk lj. Diabetes Care. 2013 Feb;36(2):457-62. doi: 10.2337/dc12-0474. Epub 2012 Nov 8. Diabetes Care. 2013. PMID: 23139371 Free PMC article.
23 results